<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00624403</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2007/22</org_study_id>
    <nct_id>NCT00624403</nct_id>
  </id_info>
  <brief_title>Comparison of Two Type of Laryngeal Mask : I-Gel &amp; LMA ProSeal</brief_title>
  <acronym>I-Gel</acronym>
  <official_title>LMA ProSeal &amp; I-Gel : a Prospective Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The i-gel is a new supra glottic airway device with a non inflatable cuff and an oesophageal
      vent. The aim of this study is to compare this device to the LMA ProSeal. The study is
      approved by the institutional ethic committee. 222 patients will be enrolled in each group.
      The objectives of the study will be to compare insertion success rate, leak pressure,
      ventilatory parameters and adverse event rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Supraglottic airway devices are now widely used for surgery requiring general anesthesia.
      Airway devices are safe and their morbidity rate is very low. The i-gel (Intersurgical Ltd,
      Wokingham, Berkshire, UK) is a new single-use non-inflatable supraglottic airway device that
      has not been evaluated in a comparative study.

      The aim of this study is to compare i-gel with the LMA ProSeal in a randomized study.
      Anesthesia protocol is standardized. The supraglottic devices are compared in term of
      insertion success rate, leak pressure, ventilatory parameters and adverse events. The aim is
      to demonstrate an enhancement in term of insertion success rate and a diminution of the
      adverse events. Statistical analysis will used percentage, confidence interval and chi 2 or
      Fischer's exact test for qualitative data. Quantitative data will be analyzed in mean,
      standard deviation. Comparison will be made with a student t test or a wilcoxon test. P &lt;
      0,05 is statistically significant.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insertion success rate</measure>
    <time_frame>At firste attempt of insertion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative morbidity</measure>
    <time_frame>Perioperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway sealing pressure</measure>
    <time_frame>Once, when efficient ventilation is reached</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accessibility for stomach tube insertion</measure>
    <time_frame>Juste after laryngeal mask insertion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibre-optic grade</measure>
    <time_frame>After insertion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">700</enrollment>
  <condition>Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LMA ProSeal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>I-Gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngeal mask insertion (LMA ProSeal)</intervention_name>
    <description>Laryngeal mask insertion</description>
    <arm_group_label>1</arm_group_label>
    <other_name>LMA ProSeal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngeal mask insertion (I-Gel)</intervention_name>
    <description>Laryngeal mask insertion</description>
    <arm_group_label>2</arm_group_label>
    <other_name>I-Gel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Weight &gt; 30 kg

          -  Surgery allowing the use of laryngeal mask as airway management

          -  Written informed consent

        Exclusion Criteria:

          -  Difficult intubation criteria (defined by French Anesthesia-Reanimation Society)

          -  Pulmonary disease

          -  Gastroesophageal reflux antecedent

          -  Coeliosurgery

          -  Inhalation risk

          -  Hiatus hernia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Marie CROS, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uniersity Hospital, Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Cros AM. [New laryngeal mask airway: easy and evolution to an better safety]. Ann Fr Anesth Reanim. 2006 Aug;25(8):804-5. Epub 2006 Jul 20. French.</citation>
    <PMID>16859880</PMID>
  </reference>
  <reference>
    <citation>Asai T. Editorial II: Who is at increased risk of pulmonary aspiration? Br J Anaesth. 2004 Oct;93(4):497-500.</citation>
    <PMID>15361474</PMID>
  </reference>
  <reference>
    <citation>Cook TM, Lee G, Nolan JP. The ProSeal laryngeal mask airway: a review of the literature. Can J Anaesth. 2005 Aug-Sep;52(7):739-60. Review.</citation>
    <PMID>16103390</PMID>
  </reference>
  <reference>
    <citation>Keller C, Brimacombe J, Kleinsasser A, Loeckinger A. Does the ProSeal laryngeal mask airway prevent aspiration of regurgitated fluid? Anesth Analg. 2000 Oct;91(4):1017-20.</citation>
    <PMID>11004067</PMID>
  </reference>
  <reference>
    <citation>Brimacombe J, Richardson C, Keller C, Donald S. Mechanical closure of the vocal cords with the laryngeal mask airway ProSeal. Br J Anaesth. 2002 Feb;88(2):296-7.</citation>
    <PMID>11878665</PMID>
  </reference>
  <reference>
    <citation>Levitan RM, Kinkle WC. Initial anatomic investigations of the I-gel airway: a novel supraglottic airway without inflatable cuff. Anaesthesia. 2005 Oct;60(10):1022-6.</citation>
    <PMID>16179048</PMID>
  </reference>
  <reference>
    <citation>Cook TM, McKinstry C, Hardy R, Twigg S. Randomized crossover comparison of the ProSeal laryngeal mask airway with the Laryngeal Tube during anaesthesia with controlled ventilation. Br J Anaesth. 2003 Nov;91(5):678-83.</citation>
    <PMID>14570790</PMID>
  </reference>
  <reference>
    <citation>Cook TM, Nolan JP, Verghese C, Strube PJ, Lees M, Millar JM, Baskett PJ. Randomized crossover comparison of the proseal with the classic laryngeal mask airway in unparalysed anaesthetized patients. Br J Anaesth. 2002 Apr;88(4):527-33.</citation>
    <PMID>12066729</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2008</study_first_submitted>
  <study_first_submitted_qc>February 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2008</study_first_posted>
  <last_update_submitted>March 9, 2015</last_update_submitted>
  <last_update_submitted_qc>March 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2015</last_update_posted>
  <responsible_party>
    <name_title>Jean-Pierre LEROY - Clinical Research and Innovation Director (General Director delegation)</name_title>
    <organization>University Hospital, Bordeaux</organization>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Laryngeal mask airway</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

